Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Steve Gruber. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Steve Gruber or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Reven Holdings | Continued...

8:30
 
Share
 

Manage episode 511919970 series 2504297
Content provided by Steve Gruber. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Steve Gruber or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Three leaders from Reven Holdings, Brian Denomme (President/COO), Peter Lange (CEO), and Michael Volk (Chief Strategy & Compliance Officer), join Steve to discuss the latest major legal development in their ongoing fight with the SEC over the frozen assets of their once-promising drug, RJX.

A federal judge has refused to dismiss Reven’s lawsuit, instead demanding more clarity on whether the SEC’s sweeping asset freeze, which halted all company operations and research, amounts to an unconstitutional government “taking.” The ruling could have billions of dollars in implications and potentially reshape how far federal agencies can go in enforcement actions.

The Reven team shares their side of the story, how a “miracle drug” meant to save lives was stopped cold, what’s next in court, and what this fight means for innovation, investors, and patients nationwide.

  continue reading

387 episodes

Artwork

Reven Holdings | Continued...

The Steve Gruber Show

28 subscribers

published

iconShare
 
Manage episode 511919970 series 2504297
Content provided by Steve Gruber. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Steve Gruber or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Three leaders from Reven Holdings, Brian Denomme (President/COO), Peter Lange (CEO), and Michael Volk (Chief Strategy & Compliance Officer), join Steve to discuss the latest major legal development in their ongoing fight with the SEC over the frozen assets of their once-promising drug, RJX.

A federal judge has refused to dismiss Reven’s lawsuit, instead demanding more clarity on whether the SEC’s sweeping asset freeze, which halted all company operations and research, amounts to an unconstitutional government “taking.” The ruling could have billions of dollars in implications and potentially reshape how far federal agencies can go in enforcement actions.

The Reven team shares their side of the story, how a “miracle drug” meant to save lives was stopped cold, what’s next in court, and what this fight means for innovation, investors, and patients nationwide.

  continue reading

387 episodes

Todos los episodios

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play